GSM6208672[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 3

Select item 2002052091.

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer

(Submitter supplied) Uterine serous carcinoma (USC), an aggressive variant of endometrial cancer representing approximately 10% of endometrial cancer diagnoses, accounts for ~39% of endometrial cancer-related deaths. We examined the role of genomic alterations in advanced-stage USC associated with outcome using paired primary-metastatic tumors (n=29) treated with adjuvant platinum and taxane chemotherapy. Comparative genomic analysis of paired primary-metastatic patient tumors included whole exome sequencing and targeted gene expression. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL27956
60 Samples

Download data: RCC, TXT, XLSX

Series

Accession:: GSE205209

ID:: 200205209

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 1000279562.

NanoString Human nCounter PanCancer IO 360 Panel

(Submitter supplied) The nCounter® PanCancer IO 360 Panel includes 750 genes that cover the key pathways at the interface of the tumor, tumor microenvironment, and immune response; in addition, there are 20 internal reference genes for data normalization. Protocol: See manufacturer's website (www.nanostring.com).